The advanced cardio tools for detecting AFib and other conditions approved in the latest Apple Watch are making some physicians nervous because of the potential for false positives.
Moreover, the approval speaks to the way the technology may evolve. Apple, to maintain good standing with the agency, should be committed to honing its algorithm to avoid unnecessarily panicking people, while spurring developers to innovate around the new heart monitoring platform.
Nevertheless, the potential for paranoia is real, experts say. Greg Marcus, a cardiologist and director of clinical research at the University of California San Francisco, said he worries that the apps could lead to unnecessary healthcare utilization, layering additional burdens on already overworked doctors.